Asia
Staidson (Beijing) BioPharmaceuticals Receives Local Approval for Drug Name Change
Municipal regulators in Beijing approved Staidson (Beijing) BioPharmaceuticals' (SHE:300204) name change to its drug production license, according to an afterhours filing on Monday in Shenzhen.The company changed the drug name to Bomitai Enzyme Alpha for Injection from STSP-0601 for Injection.
SHE:300204